Clinical trial
Post-Marketing Surveillance of Lenvima in Korean Patients
NCT02764554 is registered in ClinicalTrials.gov with Eisai Korea Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post-Marketing Surveillance of Lenvima in Korean Patients
- Lead sponsor
- Eisai Korea Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 10, 2016
- Completion date
- September 29, 2021
- Enrollment
- 132 (actual)
- Sites
- 32
Conditions
As the registry lists them; a condition with its own page is linked.
differentiated thyroid carcinoma (dtc)